Statements (55)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:DJ
|
gptkbp:acquired |
gptkb:Thermo_Fisher_Scientific
|
gptkbp:applies_to |
genomic research
|
gptkbp:based_on |
gptkb:Ion_semiconductor_sequencing
|
gptkbp:can_be |
whole genomes
|
gptkbp:developed_by |
gptkb:Ion_Torrent_Systems,_Inc.
|
gptkbp:enables |
personalized medicine
|
gptkbp:has_programs |
cancer research
|
https://www.w3.org/2000/01/rdf-schema#label |
Ion Torrent Technology
|
gptkbp:is_adopted_by |
research institutions
|
gptkbp:is_capable_of |
high accuracy
|
gptkbp:is_compared_to |
traditional methods
|
gptkbp:is_compatible_with |
various sample types
various library preparation methods various sequencing platforms |
gptkbp:is_effective_against |
other sequencing technologies
|
gptkbp:is_evaluated_by |
environmental studies
genetic studies public health studies clinical applications |
gptkbp:is_integrated_with |
bioinformatics tools
|
gptkbp:is_known_for |
its user-friendly interface
its flexibility in applications its innovative approach to sequencing its rapid turnaround time its speed and scalability |
gptkbp:is_part_of |
genomic technologies
next-generation sequencing technologies clinical genomics precision medicine initiatives Thermo Fisher Scientific's portfolio genomic medicine. |
gptkbp:is_scalable |
Sanger sequencing
|
gptkbp:is_used_for |
single-cell sequencing
exome sequencing targeted resequencing metagenomic sequencing |
gptkbp:is_used_in |
clinical diagnostics
forensic analysis pharmacogenomics transcriptomics microbial genomics |
gptkbp:is_utilized_in |
biotechnology research
metagenomics agricultural genomics |
gptkbp:measures |
p H changes
|
gptkbp:offers |
real-time sequencing data
|
gptkbp:provides |
high-throughput sequencing
|
gptkbp:provides_information_on |
variant calling
|
gptkbp:speed |
traditional sequencing methods
|
gptkbp:suitable_for |
small and large projects
|
gptkbp:supports |
RNA sequencing
|
gptkbp:uses |
gptkb:Company
|
gptkbp:bfsParent |
gptkb:Ion_Torrent_Suite
|
gptkbp:bfsLayer |
6
|